There are several clinical cutaneous manifestations of psoriasis but most commonly ... equivalent to that of a patient with metastatic cancer of the prostate. 47 At this time, there are many ...

Former President Biden’s aggressive prostate cancer diagnosis is raising questions about whether warning signs could have ...

Joe Biden's prostate cancer, marked by a high Gleason score and bone metastasis, is likely to be hormone-sensitive. Experts ...

Former President Joe Biden’s recent prostate cancer diagnosis is reigniting discussions about routine screenings for the disease, The Washington Post reported May 20. Mr. Biden, 82, announced May 18 ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

One of the most prevalent types of prostate cancer in the world, early detection may save lives. Following Joe Biden’s ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in ... also exist depending on the clinical scenario and desired outcome.

Background This study aimed to investigate the relationship between preoperative estimated prostate weight on ultrasonography and clinical manifestations of transurethral resection (TUR ...

(Mike Stocker/South Florida Sun Sentinel) She is enrolled in a pioneering clinical trial that has implications far beyond her rare form of cancer. Through Memorial Cancer Institute and its ...

Another way doctors may describe your cancer is as localised, locally advanced and metastatic prostate cancer. The type of prostate cancer tells you which type of cell the cancer started in. The most ...

Androgen deprivation is the mainstay of advanced prostate cancer treatment. Despite initial responses, almost all patients progress to castration-resistant prostate cancer (CRPC). The ...

with over 15,000 new cases of metastatic prostate cancer confirmed annually. The approval comes after the presentation of data from the ARASENS phase 3 clinical trial at the 2022 ASCO GU Cancers ...